48 3.3.9 Association entre l'évolution des traitements psychotropes et l'issue du traitement par baclofène, p.48 ,
49 3.4.1 Description des effets indésirables 49 3.4.2 Association entre les effets indésirables au cours de la 1ère année de suivi et l'issue du traitement à 1 an, p.51 ,
55 4.2.1 Limites de l'étude, p.56 ,
Les niveaux d'usage des drogues en France en 2014, Tend OFDT. mars, issue.99, p.8, 2015. ,
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II, Addiction, vol.i, issue.6 ,
DOI : 10.1111/j.1360-0443.1993.tb02093.x
Increasing trends in screening for addictives behaviors among general practitioners in France]. Rev Dépidémiologie Santé Publique, oct, vol.59, issue.5, pp.285-94, 2011. ,
Les risques d'alcoolisation excessive chez les patients ayant recours aux soins un jour donné, Etudes Résultats Dress. sept, 0192. ,
Mésusage de l'alcool : dépistage, diagnostic et traitement Recommandation de bonne pratique, 5?84. 8. International guide for monitoring alcohol consumption and related Harm, 2015. ,
The CAGE questionnaire Fast alcohol consumption evaluation: a screening instrument adapted for French general practitioners, ):1905?7. 11. Dewost A, pp.1889-95, 1984. ,
Benzodiazepines for alcohol withdrawal, CD005063. 15. Rösner S, 2010. ,
DOI : 10.1002/14651858.CD005063.pub3
Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis, PLoS ONE, vol.74, issue.2, p.87366, 2014. ,
DOI : 10.1371/journal.pone.0087366.s002
Disponible sur: http://www.hassante.fr/portail/upload/docs/application/pdf/2014- 02/selincro_04122013_synthese_ct12945_2014-02-28_12-00-18_162.pdf 20, 2013. ,
COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN, Alcohol and Alcoholism, vol.40, issue.2, pp.147-50, 2005. ,
DOI : 10.1093/alcalc/agh130
Paris: Denoël, 2008. ,
consumption 1 year after the initiation of high-dose baclofen: a retrospective study among « high-risk » drinkers Suppression of alcohol dependence using baclofen: a 2- year observational study of 100 patients. Front Psychiatry Recommandation relative à la prise en charge à titre dérogatoire du Baclofène dans le cadre d'une recommandation temporaire d'utilisation [Internet]. Haute autorité de santé -Direction de l'évaluation médicale, économique et de santé publique, 439?42. 26. de Beaurepaire R Disponible sur, pp.103-272014, 2012. ,
Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up, Alcohol Clin Exp Res. nov J Subst Abuse Treat. mai, vol.3452, issue.11, pp.24-30, 2010. ,
High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial Antidepressant-like effects of baclofen and LY367385 in the forced swim test in rats Effects of GABAB receptor ligands in animal tests of depression and anxiety, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. août Pharmacol Rep PR. oct Pharmacol Rep PR. déc Krupitsky EM, Burakov AM, vol.255859, issue.346, pp.645-55, 2006. ,
Baclofen administration for the treatment of affective disorders in alcoholic patients, Drug Alcohol Depend. sept, vol.33, issue.2, pp.157-63, 1993. ,
Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam Indifférence, recueil de témoignage sur le traitement par le baclofène de l'alcoolisme et autres addictions Le Publieur; 2012. 198 p. 38. de Beaurepaire R. The use of very high-doses of baclofen for the treatment of alcohol-dependence: a case series, Am J Med. mars Front Psychiatry, vol.1195, issue.3, pp.276-289, 2006. ,